Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Audit (A-09-11-02074)

Review of Medicare Part D Prescription Drug Event Data for Schedule II Drugs at CVS Caremark Corporation

Executive Summary

CVS Caremark Corporation did not have adequate controls to (1) prevent refills and unallowable partial fills of Schedule II drugs and (2) ensure the accuracy of certain fields in the Prescription Drug Event (PDE) records submitted for Schedule II drugs as required by Federal regulations. We found that 7 of 42 judgmentally selected PDE records represented unallowable partial fills (there were no refills), and 24 of 62 judgmentally selected PDE records contained inaccurate data when compared with the supporting documentation at the pharmacies. An additional two PDE records were missing pharmacy documentation, which prevented us from determining the accuracy of the data in the records.

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201